相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-106b-5p regulates cisplatin chemosensitivity by targeting polycystic kidney disease-2 in non-small-cell lung cancer
Shaorong Yu et al.
ANTI-CANCER DRUGS (2017)
MiR-199a-3p enhances breast cancer cell sensitivity to cisplatin by downregulating TFAM (TFAM)
Xuelong Fan et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp
Chaojing Lu et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1
Chen Tian et al.
TUMOR BIOLOGY (2016)
Cancer Statistics, 2016
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
N1-Guanyl-1,7-Diaminoheptane Sensitizes Estrogen Receptor Negative Breast Cancer Cells to Doxorubicin by Preventing Epithelial-Mesenchymal Transition through Inhibition of Eukaryotic Translation Initiation Factor 5A2 Activation
Yu Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
MicroRNA-7: A miRNA with expanding roles in development and disease
Jessica L. Horsham et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
miR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer
Shu-Bo Tian et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Overexpression of Eukaryotic Translation Initiation Factor 5A2 (EIF5A2) Correlates with Cell Aggressiveness and Poor Survival in Gastric Cancer
Qing-Bin Meng et al.
PLOS ONE (2015)
miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2
Mifang Yang et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2014)
SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin
Dong Hoon Shin et al.
CANCER RESEARCH (2014)
MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway
T. Yu et al.
ONCOGENE (2014)
Cisplatin sensitivity is enhanced in non-small cell lung cancer cells by regulating epithelial-mesenchymal transition through inhibition of eukaryotic translation initiation factor 5A2
Guodong Xu et al.
BMC PULMONARY MEDICINE (2014)
Overexpressions of MicroRNA-9 and MicroRNA-200c in Human Breast Cancers Are Associated with Lymph Node Metastasis
Jincai Wang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
N1-guanyl-1,7-diaminoheptane (GC7) enhances the therapeutic efficacy of doxorubicin by inhibiting activation of eukaryotic translation initiation factor 5A2 (eIF5A2) and preventing the epithelial-mesenchymal transition in hepatocellular carcinoma cells
Bin Lou et al.
EXPERIMENTAL CELL RESEARCH (2013)
microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1
Liduan Zheng et al.
PLOS ONE (2013)
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
Lidia Rita Corsini et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition
Wei Zhu et al.
GUT (2012)
MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility
Liang Zhu et al.
MEDICAL ONCOLOGY (2012)
Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients
Li-Ru He et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
Xiaohong Zhao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Alex Chang
LUNG CANCER (2011)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Role of microRNA in anticancer drug resistance
Tongsen Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The roles of microRNA in cancer and apoptosis
Niamh Lynam-Lennon et al.
BIOLOGICAL REVIEWS (2009)
Overexpression of EIF-5A2 predicts tumor recurrence and progression in pTa/pT1 urothelial carcinoma of the bladder
Jun-Hang Luo et al.
CANCER SCIENCE (2009)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-κB1
Li-Min Guo et al.
FEBS JOURNAL (2009)
Chemotherapy resistance in osteosarcoma: current challenges and future directions
Alexander J. Chou et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Differential expression of eIF5A-1 and eIF5A-2 in human cancer cells
PMJ Clement et al.
FEBS JOURNAL (2006)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
